scholarly journals Modeling multi-level survival data in multi-center epidemiological cohort studies: Applications from the ELAPSE project

2021 ◽  
Vol 147 ◽  
pp. 106371
Author(s):  
Evangelia Samoli ◽  
Sophia Rodopoulou ◽  
Ulla A. Hvidtfeldt ◽  
Kathrin Wolf ◽  
Massimo Stafoggia ◽  
...  
2020 ◽  
Vol 2020 ◽  
pp. 1-10
Author(s):  
June Liu ◽  
Yi Zhang

The case-cohort design is an effective and economical method in large cohort studies, especially when the disease rate is low. Case-cohort design in most of the existing literature is mainly used to analyze the univariate failure time data. But in practice, multivariate failure time data are commonly encountered in biomedical research. In this paper, we will propose methods based on estimating equation method for case-cohort designs for clustered survival data. By introducing the event failure rate, three different weight functions are constructed. Then, three estimating equations and parameter estimators are presented. Furthermore, consistency and asymptotic normality of the proposed estimators are established. Finally, the simulation results show that the proposed estimation procedure has reasonable finite sample behaviors.


Sexual Health ◽  
2016 ◽  
Vol 13 (3) ◽  
pp. 199 ◽  
Author(s):  
Eric P. F. Chow ◽  
Shayne Camilleri ◽  
Christopher Ward ◽  
Sarah Huffam ◽  
Marcus Y. Chen ◽  
...  

Background Chlamydia and gonorrhoea are the two most common sexually transmissible infections (STI) among men who have sex with men (MSM) worldwide. Infections at the pharynx and rectum are usually asymptomatic; however, the natural history of these infections remains unknown. The aim of this study is to estimate the duration of both infections at the extragenital sites from published epidemiological cohort studies. Methods: English peer-reviewed articles were searched from 1 January 2000 to 12 March 2015 in three electronic databases (MEDLINE, EMBASE and Cochrane Central). The prevalence-to-incidence ratio from each study was calculated to reflect the duration of each infection. This review followed the PRISMA guidelines and was registered in PROSPERO (CRD42014007087). Results: There were 2585 records identified, with 1721 abstracts and 52 full-text articles screened, resulting in four studies fulfilling the inclusion criteria. Pharyngeal gonorrhoea (114–138 days) had a shorter duration of infection than rectal gonorrhoea (346 days). In addition, chlamydia had a longer duration of infection at the pharynx (667 days) and rectum (579 days) compared with gonorrhoea infection. Conclusions: Gonorrhoea has a shorter duration of infection than chlamydia, suggesting that annual STI screening will be more effective at diagnosing chlamydia than gonorrhoea. The current STI guidelines recommend screening gonorrhoea and chlamydia at least once a year in MSM; it would only detect ~30% of incident pharyngeal gonorrhoea cases, with a mean duration of 4 months.


2017 ◽  
Vol 52 (4) ◽  
pp. 265-274 ◽  
Author(s):  
Shin'ichi KUDO ◽  
Jun'ichi ISHIDA ◽  
Keiko YOSHIMOTO ◽  
Hiroshige FURUTA ◽  
Fumiyoshi KASAGI

Medicina ◽  
2021 ◽  
Vol 57 (9) ◽  
pp. 905
Author(s):  
Yen-Chien Lee ◽  
Yen-Ling Lee ◽  
Chung-Yi Li

Background and Objectives:BRCA1 and BRCA2 are genes located in different chromosomes that are disproportionately associated with hereditary breast and ovarian cancer syndrome. Their association with other cancers remains to be explored. Materials and Methods: We systematically reviewed cohort studies to explore the association of BRCA 1 and BRCA2 with various cancers except lung cancer. We searched PubMed, Medline (EBSCOhost) and relevant articles published up to 10 May 2021. The odds ratio, standardised morbidity rate and cancer-specific standardised incidence ratio were pooled together as relative risk (RR) estimates. Results: Twelve studies were included for analysis. BRCA mutation increased pancreatic and uterine cancers by around 3–5- and 1.5-fold, respectively. BRCA mutation did not increase brain cancer; colorectal cancer; prostate, bladder and kidney cancer; cervical cancer; or malignant melanoma. BRCA2 increased gastric cancer with RR = 2.15 (1.98–2.33). Conclusion: The meta-analysis results can provide clinicians and relevant families with information regarding increased specific cancer risk in BRCA1 and BRCA2 mutation carriers.


2019 ◽  
Vol 3 ◽  
pp. 347
Author(s):  
Samoli E ◽  
Rodopoulou S ◽  
Klompmaker J ◽  
Wolf K ◽  
Hvidtfeldt U ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document